Cardiosense, a medical AI company transforming cardiovascular disease management, today announced the launch of SEISMIC-HF II, a nationwide study to validate the company?s machine learning algorithm for assessing

Lunit, a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certification under the Medical Device Regulation (MDR) of Lunit INSIGHT CXR4, its next-generation chest X-ray analysis solution.

AnX Robotica, a leader in advanced gastrointestinal diagnostic solutions, is proud to announce the FDA 510(k) clearance of MotiliCap? and its companion software, MotiliScan?.

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today FDA 510(k) clearance of its EZ1500 series endoscopes featuring Extended Depth of Field (EDOF?) technology.

Zylox-Tonbridge Medical Technology Co., Ltd.?today announced that its proprietary ZYLOX Unicorn? Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn?

Mindray a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon. Powered by a robust new hardware platform

Heralding an evolution of the blood pressure monitoring experience, heart health leader OMRON Healthcare today introduced home blood pressure monitors

Stryker, a global leader in medical technologies, announced that its OptaBlate basivertebral nerve ablation system (OptaBlate BVN) received 510(k) clearance from the U.S. Food and Drug Administration. OptaBlate BVNA is used in a targeted minimally invasive procedure providing long-lasting? vertebrogenic pain relief1.

Gradient Denervation Technologies announced today that its pulmonary denervation system has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

Cortechs.ai, a global leader in AI-driven neuroimaging solutions, today announced a strategic collaboration with the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) to enhance the quality of care